The research behind our first app – the Tät® app – is now complete, and that means that the app is no longer financed by government funding for research. For that reason, the doctors and researchers in our team have started up a company to continue to provide and develop the app going forward. Indeed, we believe that everybody should have access to simple and effective treatment, even in the future. We will soon launch a completely new version of the app including simpler free content and the possibility to upgrade to premium, with new content and new features. Initially the app will not be available in all countries due to the CE marking regulations. Read more here
Of the men who trained with the app for three months, 97% felt that it facilitated their training, and the proportion of those who felt that they used the correct muscles when performing muscle contractions increased from 40 to 88%. The study is now published in BJUI Compass and is available to read here
A health economic analysis of the app Tät®II for treatment of mixed and urge urinary incontinence was recently published in the International Urogynecology Journal. The study concludes that the app Tät®II is a new, cost-effective first-line treatment option, and may be a way to reach more women wishing treatment. Read more here
We have investigated the long-term results of treatment with the app Tät®II for urgency and mixed incontinence in women. The results show that the good treatment results remained after one year. The study has recently been published, read more here
In a recently published study, we investigated the quality of life of the women with urinary incontinence that participated in our three randomized controlled studies. Their quality of life was reduced because of the leakage, but not as much as for women seeking care through conventional avenues. The results suggest that e-health might reach a new group of women in need of treatment. Read the article here
